Literature DB >> 11166509

The costs of crime and the benefits of substance abuse treatment for pregnant women.

M Daley1, M Argeriou, D McCarty, J J Callahan, D S Shepard, C N Williams.   

Abstract

Although many pregnant, drug-dependent women report extensive criminal justice involvement, few studies have examined reductions in crime as an outcome of substance abuse treatment programs for pregnant women. This is unfortunate, because maternal criminal involvement can have serious health and cost implications for the unborn child, the mother and society. Using the Addiction Severity Index, differences in pre- and posttreatment criminal involvement were measured for a sample of 439 pregnant women who entered publicly funded treatment programs in Massachusetts between 1992 and 1997. Accepted cost of illness methods were supplemented with information from the Bureau of Justice Statistics to estimate the costs and benefits of five treatment modalities: detoxification only (used as a minimal treatment comparison group), methadone only, residential only, outpatient only, and residential/outpatient combined. Projected to a year, the net benefits (avoided costs of crime net of treatment costs) ranged from US$32,772 for residential only to US$3,072 for detoxification. Although all five modalities paid for themselves by reducing criminal activities, multivariate regressions controlling for baseline differences between the groups showed that reductions in crime and related costs were significantly greater for women in the two residential programs. The study provides economic justification for the continuation and possible expansion of residential substance abuse treatment programs for criminally involved pregnant women.

Entities:  

Mesh:

Year:  2000        PMID: 11166509     DOI: 10.1016/s0740-5472(00)00138-0

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  13 in total

1.  Substance abuse treatment for women: changes in the settings where women received treatment and types of services provided, 1987-1998.

Authors:  Christine E Grella; Lisa Greenwell
Journal:  J Behav Health Serv Res       Date:  2004 Oct-Dec       Impact factor: 1.505

2.  Benefit-cost in the California treatment outcome project: does substance abuse treatment "pay for itself"?

Authors:  Susan L Ettner; David Huang; Elizabeth Evans; Danielle Rose Ash; Mary Hardy; Mickel Jourabchi; Yih-Ing Hser
Journal:  Health Serv Res       Date:  2006-02       Impact factor: 3.402

3.  Cost-effectiveness analysis of four interventions for adolescents with a substance use disorder.

Authors:  Michael T French; Silvana K Zavala; Kathryn E McCollister; Holly B Waldron; Charles W Turner; Timothy J Ozechowski
Journal:  J Subst Abuse Treat       Date:  2007-06-28

4.  Risk factors in the relationship between gender and crack/cocaine.

Authors:  C W Lejuez; Marina A Bornovalova; Elizabeth K Reynolds; Stacey B Daughters; John J Curtin
Journal:  Exp Clin Psychopharmacol       Date:  2007-04       Impact factor: 3.157

Review 5.  Using administrative data for longitudinal substance abuse research.

Authors:  Elizabeth Evans; Christine E Grella; Debra A Murphy; Yih-Ing Hser
Journal:  J Behav Health Serv Res       Date:  2008-08-05       Impact factor: 1.505

6.  Gender-sensitive substance abuse treatment and arrest outcomes for women.

Authors:  Wendy B Kissin; Zhiqun Tang; Kevin M Campbell; Ronald E Claus; Robert G Orwin
Journal:  J Subst Abuse Treat       Date:  2013-10-25

Review 7.  Economic evaluation of drug abuse treatment and HIV prevention programs in pregnant women: a systematic review.

Authors:  Jennifer Prah Ruger; Christina M Lazar
Journal:  Addict Behav       Date:  2011-08-05       Impact factor: 3.913

Review 8.  Methadone exposure during lactation.

Authors:  Miguel Marcelo Glatstein; Facundo Garcia-Bournissen; Yaron Finkelstein; Gideon Koren
Journal:  Can Fam Physician       Date:  2008-12       Impact factor: 3.275

9.  Interim versus standard methadone treatment: a benefit-cost analysis.

Authors:  Robert P Schwartz; Pierre K Alexandre; Sharon M Kelly; Kevin E O'Grady; Jan Gryczynski; Jerome H Jaffe
Journal:  J Subst Abuse Treat       Date:  2013-10-14

Review 10.  Economic evaluation of interventions to treat opiate dependence : a review of the evidence.

Authors:  Christopher M Doran
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.